TipRanks
Go Ultimate55% OFF

Eastgate Biotech (ETBI) Income Statement

Eastgate Biotech Income Statement

Last quarter (Q3 2017), Eastgate Biotech's total revenue was $23.14K. In Q3, Eastgate Biotech's net income was $-1.63M. See Eastgate Biotech’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 19Dec 18Dec 17
$ 99.73K$ 136.13K$ 157.38K
$ -110.08K$ -68.88K$ -3.04K
$ 3.16M$ 1.28M$ 3.43M
Depreciation and Amortization$ 174.74K$ 111.59K$ 72.98K
$ -3.10M$ -1.23M$ -3.33M
$ -3.27M$ -1.35M$ -3.43M
$ -270.56K$ -151.34K$ -288.19K
$ -3.54M$ -1.50M$ -3.72M
$ -3.54M$ -1.50M$ -3.72M
Per Share Metrics
Basic EPS$ 0.00$ 0.00$ 0.00
Diluted EPS$ 0.00$ 0.00$ 0.00
Weighted Average Shares Outstanding1.90B1.27B0
Weighted Average Shares Outstanding (Diluted)1.90B1.27B0

Currency in USD

Eastgate Biotech Earnings and Revenue History

-4M-2M02M-4500 %-3000 %-1500 %0 %EarningsProfit Margin201720182019RevenueEarningsProfit Margin